安進公司 AMGN 深 滬
等待開盤 02-06 09:30:00 美东时间
367.80
+1.600
+0.44%
華盛通- 最 高374.90
- 今 開365.725
- 成交量 400.51万股
- 最 低 365.00
- 昨 收 366.20
- 總市值 1978.76亿
- 52周最高 374.90
- 市盈率 靜 25.85
- 換手率 0.74%
- 52周最低 254.29
- 委 比 95.78%
- 總股本 5.38亿
- 歷史最高 374.90
- 量 比 1.14
- 振 幅 2.70%
- 歷史最低 -25.919
- 每 手 1
- 風險率 23.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
Cirrus Logic Posts Upbeat Q3 Earnings, Joins Silicon Laboratories, Lear, Kennametal, CDW And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index gaining more than 250 points o...
02-05 01:24
Cantor Fitzgerald Maintains Neutral on Amgen, Raises Price Target to $350
Cantor Fitzgerald analyst Carter Gould maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $315 to $350.
02-05 00:11
财报速睇 | 安进公司 2025财年Q4营收98.51亿美元，同比增长9.2%；归母净利润13.03亿美元，同比增长108.8%
华盛资讯2月4日讯，安进公司公布2025财年Q4业绩，公司Q4营收98.51亿美元，同比增长9.2%，归母净利润13.03亿美元，同比增长108.8%。
02-04 12:02
UPDATE 1-Amgen results beat Street estimates, shares tick higher
UPDATE 1-Amgen results beat Street estimates, shares tick higher Adds share price details in paragraphs 1 and 3 By Deena Beasley Feb 3 (Reuters) - Amgen AMGN.O on Tuesday reported fourth-quarter financial results that came in ahead of Wall Street expectations, driven by higher drug sales and lower t
02-04 05:31
Amgen Sees FY2026 Sales $37.000B-$38.400B vs $37.032B Est
Amgen (NASDAQ:AMGN)sees FY2026 Sales $37.000B-$38.400B vs $37.032B Est
02-04 05:04
Amgen Sees FY2026 GAAP EPS $15.45-$16.94 vs $13.53 Est
Amgen (NASDAQ:AMGN) is looking for FY2026 GAAP EPS of $15.45-$16.94 vs $13.53 analyst estimate..
02-04 05:03
Amgen Q4 Adj. EPS $5.29 Beats $4.75 Estimate, Sales $9.866B Beat $9.464B Estimate
Amgen (NASDAQ:AMGN) reported quarterly earnings of $5.29 per share which beat the analyst consensus estimate of $4.75 by 11.37 percent. This is a 0.38 percent decrease over earnings of $5.31 per share from the same
02-04 05:02
Amgen Q4 GAAP EPS jumps over double to USD 2.45
Amgen Q4 GAAP EPS jumps over double to USD 2.45 Amgen Inc. reported its fourth quarter (Q4) and full year (FY) 2025 financial results, highlighting double-digit growth in key financial metrics. For Q4 2025, total revenues rose 9% to USD 9.9 billion, driven by product sales growth of 7% and a 10% inc
02-04 05:02
BRIEF-Amgen Outlook FY Adjusted EPS USD 21.6-23
BRIEF-Amgen Outlook FY Adjusted EPS USD 21.6-23 Feb 03 (Reuters) - Amgen outlook FY capex USD 2,600 million.
02-04 05:01
